Targeting inflammation to treat depression

September 3, 2012, Emory University

Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of General Psychiatry.

"Inflammation is the body's natural response to infection or wounding, says Andrew H. Miller, MD, senior author for the study and professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine. "However when prolonged or excessive, inflammation can damage many parts of the body, including the brain."

Prior studies have suggested that depressed people with evidence of high inflammation are less likely to respond to traditional treatments for the disorder, including anti-depressant medications and psychotherapy. This study was designed to see whether blocking inflammation would be a useful treatment for either a wide range of people with difficult-to-treat depression or only those with high levels of inflammation.

The study employed infliximab, one of the new biologic drugs used to treat autoimmune and such as rheumatoid arthritis and . A biologic drug copies the effects of substances naturally made by the body's immune system. In this case, the drug was an antibody that blocks (TNF), a key molecule in inflammation that has been shown to be elevated in some .

Study participants all had and were moderately resistant to conventional antidepressant treatment. Each participant was assigned either to infliximab or to a non-active .

When investigators looked at the results for the group as a whole, no significant differences were found in the improvement of between the drug and placebo groups. However, when the subjects with high inflammation were examined separately, they exhibited a much better response to infliximab than to placebo.

Inflammation in this study was measured using a simple blood test that is readily available in most clinics and hospitals and measures C-reactive protein or CRP. The higher the CRP, the higher the inflammation, and the higher the likelihood of responding to the drug.

"The prediction of an antidepressant response using a simple blood test is one of the holy grails in psychiatry," says Miller. "This is especially important because the blood test not only measured what we think is at the root cause of depression in these patients, but also is the target of the drug."

"This is the first successful application of a biologic therapy to depression," adds Charles L. Raison, MD, first author of the study. "The study opens the door to a host of new approaches that target the immune system to treat psychiatric diseases." Raison, formerly at Emory, is now associate professor in the Department of Psychiatry at the University of Arizona College of Medicine – Tucson.

Explore further: Inflammation in depression: Chicken or egg?

Related Stories

Inflammation in depression: Chicken or egg?

January 5, 2012
An important ongoing debate in the field of psychiatry is whether inflammation in the body is a consequence of or contributor to major depression. A new study in Biological Psychiatry has attempted to resolve the issue.

Depression could be evolutionary byproduct of immune system

March 1, 2012
Depression is common enough – afflicting one in ten adults in the United States – that it seems the possibility of depression must be "hard-wired" into our brains. This has led biologists to propose several theories ...

Childhood adversity increases risk for depression and chronic inflammation

July 3, 2012
When a person injures their knee, it becomes inflamed. When a person has a cold, their throat becomes inflamed. This type of inflammation is the body's natural and protective response to injury.

Recommended for you

Study: No evidence to support link between violent video games and behaviour

January 16, 2018
Researchers at the University of York have found no evidence to support the theory that video games make players more violent.

Study listens in on speech development in early childhood

January 15, 2018
If you've ever listened in on two toddlers at play, you might have wondered how much of their babbling might get lost in translation. A new study from the University of Toronto provides surprising insights into how much children ...

Study suggests people dislike you more for humblebragging than for regular boasting

January 12, 2018
A team of researchers from Harvard University and UNC-Chapel Hill has conducted a study regarding humblebragging—in which a person boasts about an achievement but tries to make it sound less boastful by minimizing it—and ...

Study identifies brain circuit controlling social behavior

January 11, 2018
A new study by researchers at Roche in Basel, Switzerland has identified a key brain region of the neural circuit that controls social behavior. Increasing the activity of this region, called the habenula, led to social problems ...

Can writing your 'to-do's' help you to doze? Study suggests jotting down tasks can speed the trip to dreamland

January 11, 2018
Writing a "to-do" list at bedtime may aid in falling asleep, according to a Baylor University study. Research compared sleep patterns of participants who took five minutes to write down upcoming duties versus participants ...

Tamper-resistant oxycodone tablets have no impact on overall opioid use

January 11, 2018
The introduction of tamper-resistant opioid tablets does not have an effect on rates of opioid use or harms at a population level, according to a new study led by the National Drug and Alcohol Research Centre (NDARC) at UNSW ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

jbone
5 / 5 (3) Sep 03, 2012
They seem to have pills for everything but when you want to know the actual cause of the inflammation you will be bounced around for years.
alfie_null
not rated yet Sep 04, 2012
They seem to have pills for everything but when you want to know the actual cause of the inflammation you will be bounced around for years.

Follow the money.

Preventing a malady - meh.

New medicine for malady - expensive but eventually pays out.

Repurposing an existing medicine (already been through the expensive approval process) - jackpot!

You also get bonus points if the treatment is chronic.
antonima
not rated yet Sep 04, 2012
Hey, isn't it a fact that people under chronic pain develop depression? And then they are saying 'if we can reduce pain [inflammation] our antidepressants are more likely to work'. Thats kind of obvious isn't it?

"Prior studies have suggested that depressed people with evidence of high inflammation are less likely to respond to traditional treatments for the disorder, including anti-depressant medications and psychotherapy."

Well duh, they are still in severe pain.

Thats just my take on it, I could be completely wrong. Inflammation and pain aren't necessarily in the same category of symptoms.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.